Sorafenib Induces Delayed-Onset Cutaneous Hypersensitivity: A Case Series

Sorafenib is an oral multikinase inhibitor with clinical activity against hepatocellular carcinoma (HCC) and renal cell carcinoma. Administration of sorafenib carries a variety of adverse cutaneous reactions. Common adverse effects induced by sorafenib include hand-foot skin reactions, facial erythe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohn, Kyoung-hee, Oh, Soo-yeon, Lim, Kyung-Whan, Kim, Mi-Yeong, Lee, Suh-Young, Kang, Hye-Ryun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397373/
https://www.ncbi.nlm.nih.gov/pubmed/25749785
http://dx.doi.org/10.4168/aair.2015.7.3.304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397373/
https://www.ncbi.nlm.nih.gov/pubmed/25749785
http://dx.doi.org/10.4168/aair.2015.7.3.304

Ejemplares similares